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The explosive growth of coronary computed tomography
angiography (CCTA) is related to several factors, among
which are the widespread availability of computed tomog-
raphy machines, the financial incentive associated with their
use, the strong appeal of a noninvasive visualization of the
coronary anatomy, and the clinical usefulness of the high
negative predictive value of CCTA. No other imaging
technique in cardiology has undergone a higher degree of
scrutiny for demonstration of effectiveness in the scientific
literature, nor received the level of media coverage in the lay
press. The enthusiastic adoption of CCTA contrasts with
the persisting debate on effective radiation doses associated
with CCTA (1,2) and, more importantly, on the exact role,
if any, of CCTA in the diagnostic work-up of individuals
with suspected coronary artery disease (CAD). Until now,
the prognostic significance of CAD detection by CCTA has
been limited to relatively small patient cohorts (3).
See page 849
In this issue of the Journal, Min et al. (4) convincingly
demonstrate the significance of CCTA-derived anatomic
findings on total mortality in patients without known CAD.
The sample size is almost 1 order of magnitude larger than
all previous studies on CCTA-related outcome, and the
study focuses on the “hardest” possible endpoint. The
authors report that regardless of treatment: 1) individuals
without detectable coronary atherosclerosis at CCTA have a
very favorable prognosis, and better than those with non-
obstructive CAD; 2) total mortality increases with both the
degree and extent of coronary obstruction as detected on
CCTA; and 3) the significance of these findings is more
marked in young patients and in women. It is likely that
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disclose.further analysis of this large cohort of patients will provide
us with information regarding the impact of CCTA find-
ings on therapeutic decision making. Grouches will object
that what was old is new again—that most of this informa-
tion derived from noninvasive angiography has already been
described by conventional angiography (5) and myocardial
perfusion imaging (6) studies. However, in the present
study, selection biases are less likely, as more than 90% of
patients had a low or intermediate pre-test likelihood of
CAD. In addition, the large sample size permits generalized
applicability of the findings as well as risk stratification of
individuals as categorized by age and sex. With this land-
mark study, CCTA unquestionably overcomes a significant
evidence gap: Not only is it feasible and accurate in
predicting the presence of coronary atherosclerosis, but its
findings also predict clinical outcome.
To what extent is this important for our patient? Not for
the 23,854 patients reported by Min et al. (4); rather, what
does it change for the obese 62-year-old woman with a left
bundle branch block whose mother died from a “heart
attack” at the age of 55 and who presented at the outpatient
clinic with atypical angina? Min et al. (4) CONFIRM that
strictly normal CCTA findings would be an enormous
relief. It is even likely that the favorable prognostic value of
a normal CCTA is higher than that of normal myocardial
perfusion imaging, as functional testing does not distinguish
between normal coronary arteries and nonobstructive dis-
ease. Accordingly, the hope of belonging to this very
low-risk group will continue to entice both physicians and
patients and will keep triggering a large number of CCTA
procedures. The ever-decreasing doses of radiation used
with the most recent CCTA protocols (7) will further
contribute to lowering the threshold to perform CCTA,
but, paradoxically, will contribute to increasing the number
of diagnostic conundrums in patients with suspected CAD.
The likelihood that we will discover that our patient has
some degree of coronary atherosclerosis is substantial.
Whether it is considered nonobstructive, more than 50%, or
more than 70%, in 1, 2, or 3 vessels will barely temper the
patient’s worries and will continue to convey an ambiguous
message to the physician. It has long been recognized that
the angiographic delineation of the arterial lumen and of its
narrowing poorly correlates with its effect on myocardial
blood flow (8). This relates not only to the intrinsic
inaccuracies of a luminogram to depict the true dimensions
of the narrowing, but also to the fact that the metrics of the
narrowing (the “anatomy”)—even if they were to be per-
fectly accurate—are only one of the many factors that define
patients’ symptoms and prognosis. Myocardial mass, micro-
vascular function (and hence maximal myocardial flow),
endothelial function, and coronary vasomotion are at least as
important in shaping the “physiology” of the coronary
artery. Nevertheless, the visual impression of the lumino-
gram and the sacred threshold of 50% diameter stenosis
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1-, 2-, or 3-vessel disease; and constitute the basis for the
vast majority of individual clinical decisions regarding re-
vascularization.
To understand cardiac disease and to apply the appro-
priate treatment, cardiologists must primarily be physi-
ologists. Morphology is essential but insufficient. Coro-
nary atherosclerosis does not necessarily imply myocardial
ischemia, and myocardial ischemia does not necessarily
imply the presence of focal atherosclerosis (9). CCTA-
derived luminology, with its lower resolution as com-
pared with invasive angiography, has proven incapable of
avoiding the same anatomic misclassifications (10,11). In
recognition of this weakness, several approaches have
been proposed to integrate anatomy and function in the
same setting, including the combination of adenosine
stress computed tomography myocardial perfusion imag-
ing (12) and CCTA, and the superimposition of single-
photon emission computed tomography or positron emis-
sion tomography-derived perfusion imaging with CCTA
images (13). Another promising approach consists of the
fusion of CCTA anatomic findings and color-coded
computed tomography-derived fractional flow reserve
(FFRCT) values. The method calculates FFR from
patient-specific CCTA data using computational fluid
dynamics during rest and simulated maximal coronary
hyperemic conditions (14). Preliminary results in patients
suggest that noninvasive FFRCT accurately predicts the
hemodynamic significance of coronary lesions when com-
pared to directly measured FFR during cardiac catheter-
ization (15). The method still needs to be validated in
larger patient cohorts. However, if this approach fulfills
its promises, a low radiation CCTA acquisition will
provide the clinician with anatomy (angiography) and physi-
ology (FFRCT) simultaneously. This would spur CCTA to yet
nother level and might drastically change our diagnostic
hinking in patients with suspected CAD. Expressions like “an
ntermediate lesion,” “a non–flow-limiting stenosis,” “a 40% to
0% stenosis,” and many others expressions will fade away.
he abundance of these expressions actually testifies to our
nability to act as physiologists when merely looking at an
ngiogram, whatever way this shadowgram has been produced.
f cardiac imaging is to affect the individual clinical decision-
aking process, it must reconnect us with a basic foundation of
ardiology that is, in fact, physiology (16).
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